Education
About Us
Working with TipRanks
Follow Us
Anika Therapeutics (ANIK)
NASDAQ:ANIK
Earnings Data
Report Date
May 07, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.07Last Year’s EPS
-0.06Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call reported meaningful commercial momentum (commercial channel +22% in Q4, +15% full year), strong early traction for Integrity (revenue doubled to ~$6M; procedural growth), Q4 margin expansion (63% GAAP) and improved cash flow and adjusted EBITDA that exceeded expectations. Offsetting these positives were continued OEM pricing headwinds (OEM revenue down 12% in Q4 and 17% for the year), a Hyalofast Phase III shortfall and an FDA deficiency letter that introduce regulatory uncertainty, plus full-year revenue decline of 6% and margin pressure for the year. Management provided constructive 2026 guidance with modest overall growth and improved profitability, and emphasized operational improvements and cost actions. On balance, the call highlights operational and commercial progress and a path to improved profitability while noting material regulatory and OEM-channel challenges that require execution.Company Guidance
Commercial Channel Growth
Commercial channel revenue grew 22% in Q4 to $13.3M and increased 15% for the full year to $48.4M, driven by international OA pain products and Integrity adoption.
International OA Pain Momentum
International OA pain revenue rose 28% in Q4 and 12% for the full year, led by market share gains for Monovisc, Orthovisc and Cingal across multiple regions and a lean cost structure supporting double-digit growth.
Integrity Commercial Traction
Integrity procedures and revenue more than doubled in 2025 to approximately $6M; over 2,500 surgeries performed since launch, >300 surgeons using the product, ~600 surgeries in Q4 (up 20% sequentially) and seventh consecutive quarter of sequential growth.
Operational and Margin Improvement
Q4 GAAP gross margin expanded to 63% (from 56% prior year) reflecting improved manufacturing productivity and throughput; positive operating income for Q4; expanded gross margins illustrated operating leverage as volumes rose.
Improved Profitability (Adjusted EBITDA)
Adjusted EBITDA from continuing operations was $4.5M in Q4 and $5.3M for full year 2025 (~5% of revenue), outperforming prior revised outlook (-3% to +3%).
Stronger Cash Generation and Balance Sheet
Operating cash flow improved to $11.2M in 2025 (vs $5.4M in 2024); year-end cash of $57.5M with no debt; invested $6.8M in CapEx and executed a $15M 10b5-1 buyback (to date $10.7M purchased).
Clear 2026 Guidance and Expected Improvement
2026 total company revenue guidance of $114M–$122.5M (1%–9% growth); commercial channel guidance +10%–20% ($53M–$58M); OEM channel flat to down 5% ($61M–$64.5M); adjusted EBITDA guidance of 5%–10% of revenue reflecting expected margin and cost actions.
ANIK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ANIK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 26, 2026 | $10.94 | $12.79 | +16.91% |
Nov 05, 2025 | $9.63 | $9.85 | +2.28% |
Jul 30, 2025 | $11.16 | $8.10 | -27.42% |
May 09, 2025 | $14.74 | $11.64 | -21.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Anika Therapeutics (ANIK) report earnings?
Anika Therapeutics (ANIK) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
What is Anika Therapeutics (ANIK) earnings time?
Anika Therapeutics (ANIK) earnings time is at May 07, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ANIK EPS forecast?
ANIK EPS forecast for the fiscal quarter 2026 (Q1) is -0.07.